Home treatment versus hospital care for blood clots in the lungs
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial tests whether patients with a pulmonary embolism (a blood clot in the lungs) can be safely treated at home instead of being hospitalized, when they have some signs of heart strain but are not severely ill. Participants will be randomly assigned to either home treatment or hospital care to compare safety and recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old
- You must have a confirmed blood clot in your lungs (pulmonary embolism), diagnosed within the last 24 hours
- You must not have severe symptoms that would require hospital care (like low blood pressure or needing oxygen)
- Tests must show either a strain on the right side of your heart or an elevated troponin level (a sign of heart stress)
- You must not have active cancer (other than non-melanoma skin cancer)
- You must not be pregnant or recently given birth, and you must not have legal or mental health restrictions
- Must be covered by local health insurance
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests three ways of using a catheter (a thin tube) to remove or break up blood clots in the lungs for people with a serious but stable type of pulmonary embolism. The goal is to find the best approach to improve recovery and reduce complications.
This trial tests a procedure to remove blood clots from the lungs using a tube (catheter) to open blocked vessels. It may help people with a sudden pulmonary embolism who are stable enough to undergo the procedure.
This study looks at whether a new way of grouping patients with blood clots in the lungs (pulmonary embolism) can better predict their outcomes. If you join, your health will be tracked for 30 days to see how well this new system works.
This study tests whether people with active cancer and a new blood clot in the lung can be safely treated at home instead of in the hospital. If you have cancer and a blood clot that is not causing severe symptoms, you may be able to join this trial.
This study compares different real-world treatments for a serious but stable type of blood clot in the lungs (called intermediate-high risk pulmonary embolism). It aims to see which treatments work best in everyday patients, including those with other health conditions.
This trial compares three treatments for an intermediate-high risk pulmonary embolism: a minimally invasive clot removal procedure (embolectomy), a low-dose clot-dissolving medication, or standard blood thinning (heparin). The goal is to see which approach works best to prevent worsening while reducing bleeding risks.
Hear when a new Acute Pulmonary Embolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.